Valvular Heart Disease Clinical Trial
Official title:
Tele - Cardiac Rehabilitation - Providing Pre-habilitation to Stable Patients With Valvular Heart Disease Awaiting Surgery
Cardiac rehabilitation (CR) is an integral part of cardiovascular disease management incorporating aspects of scientifically constructed appropriate physical exercise. CR has been repeatedly shown to significantly improve functional capacity, depression and wellbeing, even following short term interventions. Functional capacity is closely related to frailty, a key prognostic factor in subjects undergoing cardiac surgery. We intend to enroll 50 stable subjects with valvular heart disease scheduled for surgical intervention. Our hypothesis is that the Prehab group will improve their functional capacity to a greater degree than the usual care group, possibly associated with better clinical outcomes.
Cardiac rehabilitation (CR) is an integral part of cardiovascular disease management
incorporating aspects of scientifically constructed appropriate physical exercise, dietary
intervention, secondary prevention by pharmacotherapy, and psychological intervention. CR has
been repeatedly shown to significantly improve functional capacity, depression and wellbeing,
even following short term interventions (6-8 weeks in accordance with the date of surgery
determined for the patient.) Functional capacity is closely related to frailty, a key
prognostic factor in subjects undergoing cardiac surgery. Small studies have demonstrated
possible benefits of pre-habilitation - a multidisciplinary intervention aimed at improving
frailty in the weeks prior to surgery.
We intend to enroll 50 stable subjects with valvular heart disease scheduled for surgical
intervention. Following a comprehensive clinical and physiological evaluation subjects will
be randomized (1:1) to a Prehab arm (PHB) vs. usual care (UC). Subjects in the prehab arm
will receive a hybrid institution and home-based exercise prescription, nutritional and
psychological intervention and periodic calls. Adherence will be assessed and encouraged by
smartwatch and matching smartphone software. In the usual care arm subjects will receive
general recommendations following the baseline stress test performed by both groups (prehab
is not standard of care or guideline based). Another stress test will be performed days prior
to valve surgery.
Our hypothesis is that the Prehab group will improve their functional capacity to a greater
degree than the usual care group, possibly associated with better clinical outcomes.
The primary efficacy outcome will be exercise capacity (assessed by symptom limited stress
test - estimated METS) change from baseline (enrollment) to pre-surgery evaluation visit
(pre-op test).
Secondary measures:
Compare the 2 study arms in regard to:
1. Length of ICU and hospital stay
2. Perioperative adverse events
3. 30-day mortality or re-hospitalization
4. QOL and satisfaction
Patient / Group numbers: A total of 50 patients with established valvular disease will be
enrolled to PHB or UC after eligibility verification by cardiothoracic surgeon
Hardware: Standard off the shelf Polar sports watch (M430) with matching smartphone software.
No clinical or identifiable data will be inputted into these systems (coded subject ID only).
Clinical data and the entire program will be managed through the hospital electronic medical
record (EMR). All clinical decisions \ recommendations and events will be recorded in the
EMR.
Intervention: Patients will be randomized to pre-operative usual care or rehabilitation
program comprising of on-site (Sheba MC) and off-site training sessions. Adherence to the
rehab program will be assessed and a structured motivational program and follow-up will be
provided in order to maximize goal completion.
Following the standard rehabilitation intake process (stress test, physician visit, nurse
intake), the subjects in the prehab arm will receive physiologic consultation based on
clinical stress tests and clinical data passed from the physician. Subjects in the prehab arm
will receive an exercise prescription and execution will be assessed and periodically
adjusted in accordance to data received from the wearable device. Intensity and type of
exercise will be moderate and will comply with exercise recommendations provided by ESC
guidelines. A dedicated application will be installed on the mobile phone for patients in the
research group and they will receive a smart sports watch.
Periodic encouragements and consultations will be provided by exercise trainer, physiologist
and nurse from the cardiac rehabilitation center. A physician will be available for
consultations.
In addition to monitored physical activity, patients will receive nutritional and
psychological counseling. This is part of a multi-professional rehabilitation program
accepted by the rehabilitation center.
The control group will receive recommendations for a healthy and active lifestyle and
physician follow-up
All subjects will undergo a stress test at baseline post enrollment and again prior to
surgery.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT02241109 -
Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity
|
N/A | |
Completed |
NCT03799133 -
Safety and Efficacy of the Gastric Reactance (XL) in Patients Post-operated of Elective Cardiac Surgery
|
N/A | |
Completed |
NCT01676727 -
ADVANCE Direct Aortic Study
|
||
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT00721136 -
Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation
|
N/A | |
Recruiting |
NCT05044338 -
Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease
|
||
Recruiting |
NCT05014750 -
Frailty of Elderly With Valvular Heart Disease and the Short Term Adverse Events
|
||
Recruiting |
NCT05015829 -
Diagnostic Impact of Low-dose Dobutamine Echocardiography in Low-flow Low-gradient Aortic Stenosis
|
||
Recruiting |
NCT05078619 -
Percutaneous Coronary Intervention Before Transcatheter Aortic Valve Implantation
|
N/A | |
Recruiting |
NCT06307262 -
European Registry of Transcatheter Repair for Tricuspid Regurgitation
|
||
Completed |
NCT01624870 -
CoreValve Advance-II Study: Prospective International Post-market Study
|
||
Completed |
NCT05708690 -
Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT03797820 -
Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
|
||
Recruiting |
NCT06077721 -
Milrinone on Right Ventricular Strain in Cardiac Surgery
|
||
Not yet recruiting |
NCT04632914 -
Effect of Trunk Stabilizing Exercises on Patients With Median Sternotomy After Heart Valve Surgery
|
N/A | |
Completed |
NCT01477151 -
Randomized Isoflurane and Sevoflurane Comparison in Cardiac Surgery
|
Phase 4 | |
Terminated |
NCT03590730 -
Benefits of ICD for the Primary Prevention in Patients With Valvular Cardiomyopathy
|
||
Recruiting |
NCT06204783 -
Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions (PLUTO-II)
|
||
Enrolling by invitation |
NCT05775354 -
Reviving Early Diagnosis of Cardiovascular Disease in the Utrecht Health Project
|
N/A |